SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Neurotoxicity of MDMA: Main effects and mechanisms
16 references·0 citing·34 second hop
Neurotoxicity of MDMA: Main effects and mechanisms (2021)Neurotoxicity of MDMA: Main effects and m…Distinct acute effects of LSD, MDMA, and d-amphetamine in healthy subjects (2019)Distinct acute effects of LSD…3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings (2006)3,4-Methylenedioxymethampheta…The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”) (2003)The Pharmacology and Clinical…Methylenedioxymethamphetamine (MDMA, Ecstasy) neurotoxicity: cellular and molecular mechanisms (2003)Methylenedioxymethamphetamine…Acute Psychological Effects of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”) are Attenuated by the Serotonin Uptake Inhibitor Citalopram (2000)Acute Psychological Effects o…Serotonergic function after (±)3,4-methylene-dioxymethamphetarnine (‘Ecstasy’) in humans (1998)Serotonergic function after (…In vivo detection of short- and long-term MDMA neurotoxicity?a positron emission tomography study in the living baboon brain (1998)In vivo detection of short- a…An integrated hypothesis for the serotonergic axonal loss induced by 3,4-methylenedioxymethamphetamine. (1998)An integrated hypothesis for …Co-administration of MDMA with drugs that protect against MDMA neurotoxicity produces different effects on body temperature in the rat. (1996)Co-administration of MDMA wit…Serotonin Neurotoxicity after (±)3,4-Methylenedioxymethamphetamine (MDMA; “Ecstasy”): A Controlled Study in Humans (1994)Serotonin Neurotoxicity after…3,4-Methylenedioxymethamphetamine ("ecstasy") selectively destroys brain serotonin terminals in rhesus monkeys. (1989)3,4-Methylenedioxymethampheta…Differences between rats and mice in MDMA (methylenedioxymethylamphetamine) neurotoxicity (1988)Differences between rats and …(+/-)3,4-Methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates (1988)(+/-)3,4-Methylenedioxymetham…Differences in the central serotonergic effects of Methylenedioxymethamphetamine (MDMA) in mice and rats (1987)Differences in the central se…Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain. (1987)Biochemical and histological …3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites. (1987)3,4-Methylenedioxymethampheta…Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine. (1987)Positron emission tomographic evidence of toxic effect of MDMA (“Ecstasy”) on brain serotonin neurons in human beings (1998)3,4‐methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein (2004)Memory deficit and reduced anxiety in young adult rats given repeated intermittent MDMA treatment during the periadolescent period (2004)Dark Classics in Chemical Neuroscience: 3,4-Methylenedioxymethamphetamine (2018)An inventory for assessing different kinds of hostility. (1957)Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from nonimpulsive violent behavior (1983)Cognitive performance in (±) 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users: a controlled study (1999)Impaired cognitive performance in drug free users of recreational ecstasy (MDMA) (2000)Recreational Ecstasy/MDMA, the serotonin syndrome, and serotonergic neurotoxicity (2002)Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action (1998)The Standardized Psychometric Assessment of Altered States of Consciousness (ASCs) in Humans (1998)Psychological and Physiological Effects of MDMA (“Ecstasy”) after Pretreatment with the 5-HT2 Antagonist Ketanserin in Healthy Humans (2000)Is Ecstasy an “Empathogen”? Effects of ±3,4-Methylenedioxymethamphetamine on Prosocial Feelings and Identification of Emotional States in Others (2010)Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance (2006)Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial (2016)Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial (2016)Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects (2020)Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects (2022)The health effects of ecstasy: a literature review (2002)Acute, sub‐acute and long‐term subjective consequences of ‘ecstasy’ (MDMA) consumption in 430 regular users (2003)Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function (2004)3,4‐Methylenedioxymethamphetamine (MDMA, “Ecstasy”): pharmacology and toxicology in animals and humans (1994)(±)3,4-Methylenedioxymethamphetamine (‘Ecstasy’)-Induced Serotonin Neurotoxicity: Studies in Animals (2000)Molecular and Cellular Mechanisms of Ecstasy-Induced Neurotoxicity: An Overview (2009)Residual neurocognitive features of long‐term ecstasy users with minimal exposure to other drugs (2010)Clinical applications of hallucinogens: A review. (2016)Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms (2020)MDMA-induced neurotoxicity: Parameters of degeneration and recovery of brain serotonin neurons (1988)Subjective effects of 3,4-methylenedioxymethamphetamine in recreational users. (1988)Ecstasy (MDMA): a review of its possible persistent psychological effects (2000)Effect of illicit recreational drugs upon sleep: Cocaine, ecstasy and marijuana (2008)The effects of psilocybin and MDMA on between-network resting state functional connectivity in healthy volunteers (2014)Dose-Response Study of N,N-Dimethyltryptamine in Humans (1994)
this work references cited by second hop

References

  • 2003The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)1,271 cited
  • 19873,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites.458 cited
  • 1987Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain.453 cited
  • 1994Serotonin Neurotoxicity after (±)3,4-Methylenedioxymethamphetamine (MDMA; “Ecstasy”): A Controlled Study in Humans333 cited
  • 1988(+/-)3,4-Methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates300 cited
  • 20063,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings266 cited
  • 2000Acute Psychological Effects of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”) are Attenuated by the Serotonin Uptake Inhibitor Citalopram248 cited
  • 2019Distinct acute effects of LSD, MDMA, and d-amphetamine in healthy subjects246 cited
  • 2003Methylenedioxymethamphetamine (MDMA, Ecstasy) neurotoxicity: cellular and molecular mechanisms199 cited
  • 1998An integrated hypothesis for the serotonergic axonal loss induced by 3,4-methylenedioxymethamphetamine.181 cited
  • 19893,4-Methylenedioxymethamphetamine ("ecstasy") selectively destroys brain serotonin terminals in rhesus monkeys.162 cited
  • 1996Co-administration of MDMA with drugs that protect against MDMA neurotoxicity produces different effects on body temperature in the rat.

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

147 cited
  • 1998Serotonergic function after (±)3,4-methylene-dioxymethamphetarnine (‘Ecstasy’) in humans145 cited
  • 1998In vivo detection of short- and long-term MDMA neurotoxicity?a positron emission tomography study in the living baboon brain145 cited
  • 1987Differences in the central serotonergic effects of Methylenedioxymethamphetamine (MDMA) in mice and rats131 cited
  • 1988Differences between rats and mice in MDMA (methylenedioxymethylamphetamine) neurotoxicity125 cited
  • Cited by

    No citing works inside the corpus for this window.